Meaning
Statutory mandates under German patent law grant employee inventors an inalienable financial claim against employers who appropriate and utilize their service inventions. Under ArbEG section 9, the employee obtains a direct legal entitlement to reasonable monetary compensation as soon as the employer claims the invention. The right compensates the individual for the commercial utility and proprietary exclusivity captured by the enterprise.
The obligation persists throughout the life of the patent or trade secret exploitation, ceasing only upon formal statutory waiver, patent expiry, or complete contractual settlement.
Valuation Calculation
Compensation values follow official German administrative guidelines that combine the commercial value of the invention with a personal inventor share factor. The calculation identifies an analogous commercial royalty rate that third parties would pay for a licence in that industrial sector. That base royalty is multiplied by total relevant sales and adjusted by a grading factor between one and one hundred percent based on the inventor’s role, company resources used, and workplace duties.
Senior technical directors receive lower individual share factors than line technicians because their core job description already includes technical innovation.
Payment Structure
Remuneration payments typically distribute over time as running royalties on generated revenues or as negotiated lump-sum buyouts. Companies frequently negotiate a single lump-sum payout upon filing or patent grant to eliminate the recurring administrative burden of tracking commercial product lines over multiple decades. When disputes over the calculation emerge, either party can petition the Arbitration Board at the German Patent and Trade Mark Office prior to initiating formal litigation in the civil courts.
The arbitration proceeding provides an administrative valuation without disrupting ordinary employment relationships.
Corporate Due Diligence
Private equity acquirers and industrial joint venture partners quantify accrued but unpaid compensation liabilities under ArbEG section 9 during acquisition audits. Unsettled statutory compensation claims do not expire merely because an employment relationship ends or a company changes ownership. Target enterprises with extensive patent portfolios and high product sales face substantial retroactive liabilities if they failed to pay historical inventor royalties over preceding fiscal years.
Purchase agreements routinely manage these liabilities through indemnity provisions, special escrows, or pre-closing execution of comprehensive inventor settlement agreements.
